Lectenz Bio

Lectenz Bio is a biotechnology company based in Athens, Georgia, with a staff of 9 employees. The company reported $5.7 million in revenue. Lectenz Bio focuses on developing novel products that utilize their proprietary Lectenz® reagents and GlycoSense™ technology to streamline the identification and discovery of disease biomarkers. Lectenz Bio specializes in developing technologies and providing services related to glycan biomarkers. These biomarkers play a crucial role in disease diagnosis and treatment, but their discovery and detection are often hampered by the lack of specialized reagents and tools. The company aims to address this gap by creating innovative solutions in glycosciences that benefit both research and clinical applications. The company's unique Lectenz® reagents and GlycoSense™ technology enable the targeting of glycan biomarkers of clinical significance, facilitating their investigation and application in advancing human health. By focusing on this underexplored area, Lectenz Bio seeks to make a significant impact on improving human health through innovative glycan-based solutions. To learn more about Lectenz Bio and its offerings, visit their website at lectenz.com.